BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30007661)

  • 1. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
    Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
    Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
    Sun X; Guo Z; Yu M; Lin C; Sheng A; Wang Z; Linhardt RJ; Chi L
    J Chromatogr A; 2017 Jan; 1479():121-128. PubMed ID: 27923477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
    St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
    Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
    J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
    Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin.
    Liu X; St Ange K; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Chi L; Jin C; Jin Y; Yao Y; Linhardt RJ
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):542-553. PubMed ID: 28056526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.
    Kouta A; Hoppensteadt D; Bontekoe E; Jeske W; Duff R; Cera L; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620951851. PubMed ID: 33034200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
    Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
    Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
    Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
    Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates.
    Kouta A; Jeske W; Cera L; Farshid A; Duff R; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2021; 27():10760296211005544. PubMed ID: 33926250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
    Zhang B; Shi D; Li M; Shi F; Chi L
    Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
    Tovar AM; Santos GR; Capillé NV; Piquet AA; Glauser BF; Pereira MS; Vilanova E; Mourão PA
    Sci Rep; 2016 Oct; 6():35619. PubMed ID: 27752111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential.
    Bertini S; Fareed J; Madaschi L; Risi G; Torri G; Naggi A
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):725-734. PubMed ID: 28118750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemometric analysis of porcine, bovine and ovine heparins.
    Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
    J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
    Aquino RS; Pereira MS; Vairo BC; Cinelli LP; Santos GR; Fonseca RJ; Mourão PA
    Thromb Haemost; 2010 May; 103(5):1005-15. PubMed ID: 20216993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and chemical processing of low molecular weight heparins.
    Linhardt RJ; Gunay NS
    Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
    Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
    J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties.
    Volpi N; Mascellani G; Bianchini P
    Anal Biochem; 1992 Jan; 200(1):100-7. PubMed ID: 1595883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.